Maven Health

Switzerland
Malters, Lucerne, Switzerland

Company profile

Maven Health company profile

Maven Health operates a B2B2C model with healthcare professionals like clinics and registered nutritionists as customers. The core product is the non-invasive saliva metabolite test, measuring 47 metabolites ranging from amino acids to short-chain fatty acids. These are critical parameters to assess metabolic health. It is used in small practices or clinics, standalone or in tandem with other tests (genetic, gut microbiome etc.). Maven Health is an asset-light model and does not own or operate the hardware (nuclear magnetic resonance). We currently operate in CH, NL and are expanding to other European countries. We are looking for starting pilots in the USA late 2025.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2024-01-09

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
6
Total equity funding
$434,603
Last funding
Grant / $11,375 / 2024-02-27
Last equity funding
Pre Seed / $412,936
Investors
8
Lead investors
6
Founders
2
Articles
9

Founders and investors

Founders

Christopher WallKevin Hof

Lead investors

DayOne acceleratorEPFL Innovation ParkFederal Polytechnic School of LausanneFounderful CampusFuture of Health GrantVenture Kick

Investors

Federal Polytechnic School of LausanneFounderful CampusFuture of Health GrantS2S VenturesVenture Kick